Catheter Ablation of Ventricular Tachycardia in Histologically Confirmed, Clinically Diagnosed, and Suspected Cardiac Sarcoidosis
Patients with histologically confirmed CS had worse VT ablation outcomes than those with clinical/suspected CS. This difference may be driven by a higher prevalence of systemic sarcoidosis in the former group. These findings highlight the need for a comprehensive management approach in both groups.
Authors
- Poojan Prajapati (ORCID: https://orcid.org/0009-0005-4959-1344)
- Hicham El Masry (ORCID: https://orcid.org/0000-0002-2470-2862)
- Komandoor S. Srivathsan (ORCID: https://orcid.org/0000-0001-9732-0243)
- Dan Sorajja (ORCID: https://orcid.org/0000-0003-1976-6420)
- Carlos A. Rojas (ORCID: https://orcid.org/0000-0002-1312-1288)
- Hema Srikanth Vemulapalli (ORCID: https://orcid.org/0009-0001-2942-1031)
- Juan F. Rodriguez‐Riascos (ORCID: https://orcid.org/0000-0002-8271-9128)
- Clinton Jokerst
- Padmapriya Muthu (ORCID: https://orcid.org/0009-0002-5561-0431)
Institutions
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Circulation Journal
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1253/circj.cj-25-0285
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00